ClinicalTrials.Veeva

Menu

Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II)

Medical University of Vienna logo

Medical University of Vienna

Status and phase

Unknown
Phase 3

Conditions

CRPS Type II

Treatments

Procedure: SUBCUTANEOUS VENOUS SYMPATHECTOMY (RSVS)

Study type

Interventional

Funder types

Other

Identifiers

NCT01392599
026/2009

Details and patient eligibility

About

The purpose of this study is to investigated and evaluated the effectiveness of a new surgical technique for the treatment of severe chronic pain stages (Complex Regional Pain Syndrome Type II).

Full description

For 140 years the treatment of Complex Regional Pain Syndromes Type II (CRPS II) has been an unsolved problem. Recent findings in animal models assume that CRPS Type II is maintained by a coupling of newly sprouted sympathetic and sensible fibres. Therapeutic approaches have included conventional pain medication, physical therapy, sympathetic blocks, transcutaneous or spinal cord stimulation, injections or infusion therapies and sympathectomy. Alone or in combination these therapies often yielded unfavorable results. The majority of physicians dealing with CRPS patients are convinced that a surgical treatment of the affected extremity only exacerbates the symptoms, especially its hallmark excruciating pain.

Patients with a CRPS Type II at the upper or the lower limb will be included in the study after ineffective pain therapy for more than 6 months. The most proximal region of pain associated with CRPS can be localized and 2% Lidocain will be injected into that area. If the sympathetic, deep, burning pain can be blocked repeatedly with these injections, the subcutaneous veins in the previously determined area will be surgically removed. This operation should lead to the permanent resolution of symptoms.

A visual analogue scale (VAS), the Nottingham Health Profile (NHP), thermography and physical examinations will be used to evaluate the outcome of the operation.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients suffering from CRPS Type II after after ineffective pain therapy for more than 6 months.

Exclusion criteria

  • Ineffective testinfiltration with an local anesthetic Pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Surgery
Experimental group
Description:
Patients with CRPS Type II
Treatment:
Procedure: SUBCUTANEOUS VENOUS SYMPATHECTOMY (RSVS)

Trial contacts and locations

1

Loading...

Central trial contact

Lukas K Kriechbaumer, MD; Wolfgang Happak, Prof., MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems